Armata Pharmaceuticals, Inc.
ARMP
$2.68
$0.2510.29%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.71M | -426.00K | -18.92M | -41.36M | -67.04M |
| Total Depreciation and Amortization | 1.44M | 1.39M | 1.33M | 1.24M | 1.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.37M | -33.90M | -17.86M | 5.13M | 29.05M |
| Change in Net Operating Assets | -2.94M | -1.60M | -2.10M | -2.73M | -1.70M |
| Cash from Operations | -31.58M | -34.55M | -37.55M | -37.73M | -38.55M |
| Capital Expenditure | -511.00K | -1.73M | -1.88M | -4.36M | -7.53M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 10.00K | 10.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -511.00K | -1.73M | -1.88M | -4.35M | -7.52M |
| Total Debt Issued | 10.00M | 10.00M | 34.89M | 34.89M | 59.69M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 88.00K | 130.00K | 130.00K | 135.00K |
| Repurchase of Common Stock | -75.00K | -75.00K | -61.00K | -104.00K | -43.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.93M | 10.01M | 34.96M | 34.92M | 59.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.17M | -26.26M | -4.47M | -7.16M | 13.71M |